言語を選択

Nucleocapsid protein

Nucleocapsid protein 詳細

英語名	Nucleocapsid proteins	市販薬剤の数	0
治験薬の数	2	ターゲットの別称	Nucleocapsid Proteins
研究＆開発段階	Phase 2 Clinical

英語名	Nucleocapsid proteins
ターゲットの別称	Nucleocapsid Proteins
市販薬剤の数	0
治験薬の数	2
研究＆開発段階	Phase 2 Clinical

Nucleocapsid protein 製品リスト

属性
Protein (20)Kits (1)
製品ライブラリ
オンライン (21)
種
SARS-CoV-2 (15)MERS (1)SARS (1)HCoV-NL63 (1)HCoV-OC43 (1)HCoV-229E (1)SFTS virus (1)
タグ
His Tag (18)His Tag & Avi Tag (2)- (1)
マーカー
Unconjugated (18)Biotin-labeled (2)- (1)

製品番号	種	発現システム	製品説明
HOT NUN-C51H9	SARS-CoV-2	E. coli	SARS-CoV-2 (COVID-19) Nucleocapsid protein, His Tag
HOT NUN-C5227	SARS-CoV-2	HEK293	SARS-CoV-2 (COVID-19) Nucleocapsid protein, His Tag
HOT NUN-C52Hu	SARS-CoV-2	HEK293	SARS-CoV-2 Nucleocapsid protein, His Tag (BA.2&BA.3/Omicron)
NUN-C5143	SARS-CoV-2	E. coli	SARS-CoV-2 Nucleocapsid Protein NTD, His Tag (MALS verified)
NUN-C5145	SARS-CoV-2	E. coli	SARS-CoV-2 Nucleocapsid Protein CTD, His Tag (MALS verified)
NUN-C51H2	SARS-CoV-2	E. coli	SARS-CoV-2 (COVID-19) Nucleocapsid protein, His Tag
NUN-C5221	SARS-CoV-2	HEK293	SARS-CoV-2 (COVID-19) Nucleocapsid protein, His Tag
NUN-C52H8	SARS-CoV-2	HEK293	SARS-CoV-2 Nucleocapsid protein (D3L, R203K, G204R, S235F), His Tag
NUN-C52Hr	SARS-CoV-2	HEK293	SARS-CoV-2 Nucleocapsid protein (D63G, R203M, G215C, D377Y), His Tag
NUN-C52Ht	SARS-CoV-2	HEK293	SARS-CoV-2 Nucleocapsid protein, His Tag (B.1.1.529/Omicron)

総数量21

Nucleocapsid proteinバックグランド

The nucleocapsid (NP) protein of Severe Fever with Thrombocytopenia Syndrome virus (SFTSV) is encoded by the S segment of its tripartite RNA genome. NP plays a central role in viral replication by encapsidating the genomic RNA and forming ribonucleoprotein complexes with the polymerase. It is highly conserved among SFTSV strains and strongly immunogenic, making it a major target for diagnostic assays and serological studies. Because of its abundance and stability, recombinant NP is widely used as an antigen for ELISA, rapid tests, and antibody development against this emerging tick-borne phlebovirus.

Nucleocapsid protein分子の別称

Nucleocapsid protein,NP,Protein N

治験薬に関する情報

英語名	研究コード	研究開発ステージ	会社	適応症	臨床試験
Zelicapavir	EDP-938; EP-023938	Phase 2 Clinical	Enanta Pharmaceuticals Inc	Respiratory Syncytial Virus Infections	詳細
PF-07923567	RV-299; PF-07923567	Phase 1 Clinical	Reviral Ltd	Respiratory Syncytial Virus Infections	詳細